Literature DB >> 2296239

Topography of human aortic sudanophilic lesions.

J F Cornhill1, E E Herderick, H C Stary.   

Abstract

The topographic distribution of sudanophilic lesions in the human aorta has been defined using probability-of-occurrence maps for a population dying of trauma (male, black and white, 15-29 years, n = 109). The maps demonstrate that sudanophilic lesions are localized with a characteristic topography. Regions of high probability (greater than 60%) occurred in close proximity to regions of low probability (less than 10%). Although some high-probability areas are associated with expected low wall shear stress regions, many other high probability areas are not and thus no specific causal hemodynamic localizing factors could be identified. The probability maps do however form an important basis for the development of rational strategies of tissue sampling in studies concerned with the characterization of localizing factors (biochemical, cellular, hemodynamic, and structural) and their relationship to putative atherogenic mechanisms.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2296239

Source DB:  PubMed          Journal:  Monogr Atheroscler        ISSN: 0077-099X


  13 in total

Review 1.  The convergence of haemodynamics, genomics, and endothelial structure in studies of the focal origin of atherosclerosis.

Authors:  Peter F Davies; Denise C Polacek; Congzhu Shi; Brian P Helmke
Journal:  Biorheology       Date:  2002       Impact factor: 1.875

2.  Quantification of hemodynamics in abdominal aortic aneurysms during rest and exercise using magnetic resonance imaging and computational fluid dynamics.

Authors:  Andrea S Les; Shawn C Shadden; C Alberto Figueroa; Jinha M Park; Maureen M Tedesco; Robert J Herfkens; Ronald L Dalman; Charles A Taylor
Journal:  Ann Biomed Eng       Date:  2010-02-09       Impact factor: 3.934

Review 3.  Flow-mediated endothelial mechanotransduction.

Authors:  P F Davies
Journal:  Physiol Rev       Date:  1995-07       Impact factor: 37.312

Review 4.  Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives.

Authors:  Jeng-Jiann Chiu; Shu Chien
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

5.  PECAM-1 is a critical mediator of atherosclerosis.

Authors:  Hazel Y Stevens; Benoît Melchior; Kelly S Bell; Sujin Yun; Jiunn-Chern Yeh; John A Frangos
Journal:  Dis Model Mech       Date:  2008-09-18       Impact factor: 5.758

6.  Immunology of atherosclerosis. Demonstration of heat shock protein 60 expression and T lymphocytes bearing alpha/beta or gamma/delta receptor in human atherosclerotic lesions.

Authors:  R Kleindienst; Q Xu; J Willeit; F R Waldenberger; S Weimann; G Wick
Journal:  Am J Pathol       Date:  1993-06       Impact factor: 4.307

7.  Cataloguing the geometry of the human coronary arteries: a potential tool for predicting risk of coronary artery disease.

Authors:  Hui Zhu; Zhaohua Ding; Robert N Piana; Thomas R Gehrig; Morton H Friedman
Journal:  Int J Cardiol       Date:  2008-07-01       Impact factor: 4.164

Review 8.  Composition and classification of human atherosclerotic lesions.

Authors:  H C Stary
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

9.  GATA2 is associated with familial early-onset coronary artery disease.

Authors:  Jessica J Connelly; Tianyuan Wang; Julie E Cox; Carol Haynes; Liyong Wang; Svati H Shah; David R Crosslin; A Brent Hale; Sarah Nelson; David C Crossman; Christopher B Granger; Jonathan L Haines; Christopher J H Jones; Jeffery M Vance; Pascal J Goldschmidt-Clermont; William E Kraus; Elizabeth R Hauser; Simon G Gregory
Journal:  PLoS Genet       Date:  2006-07-20       Impact factor: 5.917

10.  The relationship between wall shear stress distributions and intimal thickening in the human abdominal aorta.

Authors:  Michael Bonert; Richard L Leask; Jagdish Butany; C Ross Ethier; Jerry G Myers; K Wayne Johnston; Matadial Ojha
Journal:  Biomed Eng Online       Date:  2003-11-26       Impact factor: 2.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.